MBD1 is a mammalian protein that binds symmetrically methylated CpG sequenc
es and regulates gene expression in association with DNA methylation. This
protein possesses a conserved sequence, named methyl-CpG binding domain (MB
D), among a family of methyl-CpG binding proteins that mediate the biologic
al consequences of the methylation. In addition, MBD1 has at least five iso
forms due to alternative splicing events, resulting in the presence of CXXC
1, CXXC2, and CXXC3 in MBD1 isoforms v1 (MBD1v1) and MBD1v2, and CXXC1 and
CXXC2 in MBD1v3 and -v4. In the present study, we have investigated the sig
nificance of MBD, CXXC, and the C-terminal transcriptional repression domai
n (TRD) in MBD1. A bacterially expressed MBD binds efficiently to densely m
ethylated rather than to sparsely methylated DNAs. In both methylation-defi
cient Drosophila melanogaster SL2 cells and mammalian CHO-K1 cells, MBD1v1
represses transcription preferentially from both unmethylated and sparsely
methylated promoters, while MBD1v3 inhibits densely methylated but not unme
thylated promoter activities. The CXXC3 sequence in MBD1v1 is responsible f
or the ability to bind unmethylated promoter. Furthermore, we have construc
ted mutant-type MBD1s in which the functionally important residues Arg22, A
rg30, Asp32, Tyr34, Arg44, Ser45, and Tyr52 are changed to alanine to inves
tigate the correlation between the structure and function of the MBD in MBD
1. Excepting those for Ser45 and Tyr52, none of the recombinant MBD mutants
bound to the densely methylated or unmethylated DNAs, and green fluorescen
t protein-fused MBD1 mutants did not localize properly in the nucleus. All
the MBD1v1 and -v3 mutants lost the activity of methylation-dependent gene
repression. Based on these findings we have concluded;that MBD1 acts as a t
ranscriptional regulator depending on the density of methyl-CpG pairs throu
gh the cooperation of MBD, CXXC, and TRD sequences.